Sana Biotechnology’s investigational allogeneic islet cell therapy has survived and secreted insulin for more than one year ...

patient cohort fully enrolled with an average time since transplant of approximately 8 months- 100% insulin independence achieved in 10 ...

News and commentary from the endocrinology world ...

In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...

The team, in collaboration with Shanghai Changzheng Hospital, has conducted regenerative islet transplantation surgeries using autologous and allogeneic stem cell-derived islets on three patients with ...

Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression. 14-Month Follow-up Data Sho ...

Add Yahoo as a preferred source to see more of our stories on Google. For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become “overwhelming.” ...

Lantidra therapy infuses healthy islet cells into patients' livers, with some achieving insulin independence. University ...

A vascularized organoid model of hormone-secreting cells in the pancreas has been developed, with potential to improve diabetes research and cell-based therapies. “Our results highlight the importance ...

Tokyo, Japan – Researchers from Tokyo Metropolitan University have studied pancreatic islet cell loss in people with no previous pancreatic problems. They identified key trends in the types of cells ...

Researchers have devised the right conditions to grow vascularized stem cell islets. The image shows vasculature (red) tightly wrapped around insulin-producing cells (green) in the islets (blue).

Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...